Anti-beta Dystroglycan antibody
3
(3 Reviews)
|
(6 Publications)
Rabbit Polyclonal DAG1 antibody. Suitable for WB and reacts with Human samples. Cited in 6 publications.
View Alternative Names
Dystroglycan 1, Dystroglycan, Dystrophin-associated glycoprotein 1
- WB
Unknown
Western blot - Anti-beta Dystroglycan antibody (AB43125)
Lanes 1-3 : Merged signal (red and green). Green - ab43125 observed at 43 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab43125 Anti-beta Dystroglycan antibody was shown to specifically react with beta Dystroglycan in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266263 (knockout cell lysate ab257192) was used. Wild-type and beta Dystroglycan knockout samples were subjected to SDS-PAGE. ab43125 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-beta Dystroglycan antibody (ab43125) at 1/500 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
DAG1 knockout HEK293T cell lysate at 20 µg
Lane 3:
Human skeletal muscle tissue lysate at 20 µg
Predicted band size: 97 kDa
Observed band size: 43 kDa
false
- WB
Lab
Western blot - Anti-beta Dystroglycan antibody (AB43125)
Lanes 1-3 : Merged signal (red and green). Green - ab43125 observed at 43 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab43125 Anti-beta Dystroglycan antibody was shown to specifically react with beta Dystroglycan in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266263 (knockout cell lysate ab257192) was used. Wild-type and beta Dystroglycan knockout samples were subjected to SDS-PAGE. ab43125 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-beta Dystroglycan antibody (ab43125) at 1/500 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human DAG1 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-dag1-knockout-hek-293t-cell-line-ab266263'>ab266263</a>)
Lane 2:
DAG1 knockout HEK293T cell lysate at 20 µg
Lane 3:
Human skeletal muscle tissue lysate at 20 µg
Predicted band size: 97 kDa
Observed band size: 43 kDa
false
- WB
Lab
Western blot - Anti-beta Dystroglycan antibody (AB43125)
ab43125 was shown to react with DAG1 in wild-type A431 cells in Western blot with loss of signal observed in a DAG1 knockout cell line. Wild-type A431 and DAG1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab43125 overnight at 4 °C at a 1/500 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-beta Dystroglycan antibody (ab43125) at 1/500 dilution
Lane 1:
Wild-type A431 lysate at 90 µg
Lane 2:
DAG1 knock-out A431 lysate at 90 µg
false
- WB
Project
Western blot - Anti-beta Dystroglycan antibody (AB43125)
All lanes:
Western blot - Anti-beta Dystroglycan antibody (ab43125) at 1 µg/mL
Lane 1:
Human brain tissue lysate - total protein (<a href='/en-us/products/unavailable/human-brain-tissue-lysate-total-protein-ab29466'>ab29466</a>) at 10 µg
Lane 2:
Human heart tissue lysate - total protein (<a href='/en-us/products/unavailable/human-heart-tissue-lysate-total-protein-ab29431'>ab29431</a>) at 10 µg
Lane 3:
Human skeletal muscle tissue lysate - total protein (<a href='/en-us/products/unavailable/human-skeletal-muscle-tissue-lysate-total-protein-ab29330'>ab29330</a>) at 10 µg
Secondary
All lanes:
IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution
Predicted band size: 97 kDa
Observed band size: 43 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Beta Dystroglycan acts as a structural and signaling molecule within the dystrophin-glycoprotein complex. This complex stabilizes the sarcolemma during muscle contraction and helps in protecting muscle fibers from injury. Beta Dystroglycan also contributes to cellular signaling pathways by interacting with various intracellular proteins like dystrophin and alpha dystroglycan. It regulates cell adhesion and migration processes critical for tissue maintenance and repair.
Pathways
Beta Dystroglycan plays a critical role in the integrity of the dystrophin-associated glycoprotein complex. It is involved in the AKT signaling pathway which is essential for cellular growth and survival. Moreover beta Dystroglycan interacts closely with proteins such as dystrophin and utrophin facilitating their functions in muscle cells. Its interactions help maintain cell membrane stability and signal transduction processes important for normal cellular functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 12:3186 PubMed35210456
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of physiology 597:4831-4850 PubMed31340406
2019
Applications
Unspecified application
Species
Unspecified reactive species
HRB open research 1:17 PubMed35528858
2018
Applications
Unspecified application
Species
Unspecified reactive species
Cerebral cortex (New York, N.Y. : 1991) 28:4049-4062 PubMed30169756
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of proteomics 191:212-227 PubMed29408692
2018
Applications
Unspecified application
Species
Unspecified reactive species
BMC research notes 10:601 PubMed29157305
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com